 |
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2023, vol. 29, issue3
Subject Area: Medicine
-
DOI: 10.5272/jimab.2023293.5036
Published online: 261 July 2023
Original article
J of IMAB. 2023 Jul-Sep;29(3):5036-5038
SMOKING AS A RISK FACTOR IN ATHLETES
Iva Miteva1
, Valentin Valchev2, Todor Kundurzhiev1,
1) Department of Occupational Medicine, Faculty of Public Health, Medical University - Sofia, Bulgaria.
2) Department of Physiology and Biochemistry, Faculty of Sport, National Sport Academy „Vassil Levski” - Sofia, Bulgaria.
ABSTRACT:
After the pandemic and at the beginning of 2023, our team carried out a survey among active athletes about the risks associated with smoking.
The purpose of the study is to assess smoking as a risk factor in athletes using a survey method.
Methods: The respondents were asked to participate anonymously in a survey consisting of 14 questions. We surveyed 50 active athletes (35 men and 15 women).
Results: Forty-three of the participants were aged between 18 and 22 years old, and 7 were aged between 23 and 27 years old. Results: 30% of the surveyed athletes are smokers, 40% are non-smokers and 30% used to smoke in the past; 66% are familiar with the risk of smoking; 42% would support a ban on smoking in public; 22% report that cigarettes influence athletic achievements; 80% of the athletes consider that they are smoking due to stress; 34% think that only a health problem could make them quit smoking.
Conclusions: The fact that 66% of the athletes are aware of the risks associated with smoking gives us hope in the combat against smoking. The effect of cigarettes on the human body should be emphasized. The survey showed that there are insufficient campaigns to raise awareness about the harmful effects of smoking which is key to quitting cigarettes.
Keywords: smoking, sport, athletes, stress,
- Download FULL TEXT /PDF 731 KB/
Please cite this article as: Miteva I, Valchev V, Kundurzhiev T. Smoking as a Risk Factor in Athletes. J of IMAB. 2023 Jul-Sep;29(3):5036-5038. [Crossref - 10.5272/jimab.2023293.5036]
Correspondence to: Iva Miteva, Department of Occupational Medicine, Faculty of Public Health, Medical University-Sofia; 8, Byalo More Str., Sofia 1527, Bulgaria; E-mail: i.miteva@foz.mu-sofia.bg
REFERENCES:
1. Keto J, Ventola H, Jokelainen J, Linden K, Keinänen-Kiukaanniemi S, Timonen M, et al. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart. 2016 Jul 12;3(2):e000358. [PubMed]
2. WHO report on the global tobacco epidemic, 2013: enforcing bans on tobacco advertising, promotion and sponsorship. 11 July 2013. [Internet]
3. Lerman C, Niaura R. Applying genetic approaches to the treatment of nicotine dependence. Oncogene. 2002 Oct 21;21(48):7412-20. [PubMed]
4. Jha P, Peto R, Zatonski W, Boreham J, Jarvis MJ, Lopez AD. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet. 2006 Jul 29;368(9533):367-70. [PubMed]
5. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999 Mar 9;99(9):1165-72. [PubMed]
6. Varela-Carver A, Parker H, Kleinert C, Rimoldi O. Adverse effects of cigarette smoke and induction of oxidative stress in cardiomyocytes and vascular endothelium. Curr Pharm Des. 2010;16(23):2551-8. [PubMed]
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 Mar 5;105(9):1135-43. [PubMed]
8. Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis. 2003 Jul-Aug;46(1):91-111. [PubMed]
9. Mihael Pittilo R. Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Pathol. 2000 Aug;81(4):219-30. [PubMed]
10. Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Paharmacol. 2007 Oct;5(4):276-92. [PubMed]
11. Hori M, Tanaka H, Wakai K, Sasazuki S, Katanoda K. Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies. Jpn J Clin Oncol. 2016 Oct;46(10):942-951. [PubMed]
12. Ikeda N, Inoue M, Iso H, Ikeda S, Satoh T, Noda M, et al. Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med. 2012 Jan;9(1):e1001160. [PubMed]
13.Halpern MT, Shikiar R, Rentz AM, Khan ZM. Impact of smoking status on workplace absenteeism and productivity. Tob Control. 2001 Sep;10(3):233-8. [PubMed]
14. Suwa K, Flores NM, Yoshikawa R, Goto R, Vietri J, Igarashi A. Examining the association of smoking with work productivity and associated costs in Japan. J Med Econ. 2017 Sep;20(9):938-944. [PubMed ]
15. Tashiro S, Kato K, Kitazawa M, Fujihara K, Kodama S, Tashiro M, et al. Differences in occupational stress by smoking intensity and gender in cross-sectional study of 59 355 Japanese employees using the Brief Job Stress Questionnaire (BJSQ): the Niigata Wellness Study. BMJ Open. 2022 Apr 8;12(4):e055577. [PubMed]
Received: 22 February 2023
Published online: 26 July 2023